TY - JOUR AU - Ferreira, L. M. PY - 2010 DA - 2010// TI - Cancer metabolism: the Warburg effect today JO - Exp Mol Pathol VL - 89 UR - https://doi.org/10.1016/j.yexmp.2010.08.006 DO - 10.1016/j.yexmp.2010.08.006 ID - Ferreira2010 ER - TY - JOUR AU - Upadhyay, M. AU - Samal, J. AU - Kandpal, M. AU - Singh, O. V. AU - Vivekanandan, P. PY - 2013 DA - 2013// TI - The Warburg effect: insights from the past decade JO - Pharmacol Ther VL - 137 UR - https://doi.org/10.1016/j.pharmthera.2012.11.003 DO - 10.1016/j.pharmthera.2012.11.003 ID - Upadhyay2013 ER - TY - JOUR AU - Potter, M. AU - Newport, E. AU - Morten, K. J. PY - 2016 DA - 2016// TI - The Warburg effect: 80 years on JO - Biochem Soc Trans VL - 44 UR - https://doi.org/10.1042/BST20160094 DO - 10.1042/BST20160094 ID - Potter2016 ER - TY - JOUR AU - Vander Heiden, M. G. AU - Cantley, L. C. AU - Thompson, C. B. PY - 2009 DA - 2009// TI - Understanding the Warburg effect: the metabolic requirements of cell proliferation JO - Science VL - 324 UR - https://doi.org/10.1126/science.1160809 DO - 10.1126/science.1160809 ID - Vander Heiden2009 ER - TY - JOUR AU - Koppenol, W. H. AU - Bounds, P. L. AU - Dang, C. V. PY - 2011 DA - 2011// TI - Otto Warburg’s contributions to current concepts of cancer metabolism JO - Nat Rev Cancer VL - 11 UR - https://doi.org/10.1038/nrc3038 DO - 10.1038/nrc3038 ID - Koppenol2011 ER - TY - JOUR AU - Bensinger, S. J. AU - Christofk, H. R. PY - 2012 DA - 2012// TI - New aspects of the Warburg effect in cancer cell biology JO - Semin Cell Dev Biol VL - 23 UR - https://doi.org/10.1016/j.semcdb.2012.02.003 DO - 10.1016/j.semcdb.2012.02.003 ID - Bensinger2012 ER - TY - JOUR AU - Bhattacharya, B. AU - Mohd Omar, M. F. AU - Soong, R. PY - 2016 DA - 2016// TI - The Warburg effect and drug resistance JO - Br J Pharmacol VL - 173 UR - https://doi.org/10.1111/bph.13422 DO - 10.1111/bph.13422 ID - Bhattacharya2016 ER - TY - JOUR AU - Liberti, M. V. AU - Locasale, J. W. PY - 2016 DA - 2016// TI - The Warburg effect: how does it benefit cancer cells? JO - Trends Biochem Sci VL - 41 UR - https://doi.org/10.1016/j.tibs.2015.12.001 DO - 10.1016/j.tibs.2015.12.001 ID - Liberti2016 ER - TY - JOUR AU - Otto, A. M. PY - 2016 DA - 2016// TI - Warburg effect(s)—a biographical sketch of Otto Warburg and his impacts on tumor metabolism JO - Cancer Metab VL - 4 UR - https://doi.org/10.1186/s40170-016-0145-9 DO - 10.1186/s40170-016-0145-9 ID - Otto2016 ER - TY - JOUR AU - Ngo, H. AU - Tortorella, S. M. AU - Ververis, K. AU - Karagiannis, T. C. PY - 2015 DA - 2015// TI - The Warburg effect: molecular aspects and therapeutic possibilities JO - Mol Biol Rep VL - 42 UR - https://doi.org/10.1007/s11033-014-3764-7 DO - 10.1007/s11033-014-3764-7 ID - Ngo2015 ER - TY - JOUR AU - Ho, W. L. AU - Hsu, W. M. AU - Huang, M. C. AU - Kadomatsu, K. AU - Nakagawara, A. PY - 2016 DA - 2016// TI - Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma JO - J Hematol Oncol VL - 9 UR - https://doi.org/10.1186/s13045-016-0334-6 DO - 10.1186/s13045-016-0334-6 ID - Ho2016 ER - TY - JOUR AU - Li, X. B. AU - Gu, J. D. AU - Zhou, Q. H. PY - 2015 DA - 2015// TI - Review of aerobic glycolysis and its key enzymes—new targets for lung cancer therapy JO - Thorac Cancer VL - 6 UR - https://doi.org/10.1111/1759-7714.12148 DO - 10.1111/1759-7714.12148 ID - Li2015 ER - TY - JOUR AU - Lv, X. B. AU - Liu, L. AU - Cheng, C. AU - Yu, B. AU - Xiong, L. AU - Hu, K. PY - 2015 DA - 2015// TI - SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancer JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep17940 DO - 10.1038/srep17940 ID - Lv2015 ER - TY - JOUR AU - Qian, S. AU - Li, J. AU - Hong, M. AU - Zhu, Y. AU - Zhao, H. AU - Xie, Y. PY - 2016 DA - 2016// TI - TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia JO - J Hematol Oncol VL - 9 UR - https://doi.org/10.1186/s13045-016-0360-4 DO - 10.1186/s13045-016-0360-4 ID - Qian2016 ER - TY - JOUR AU - Chrysi, X. AU - Carol, W. AU - Alan, W. AU - Hugh, M. AU - Arran, T. AU - Langdon, S. P. PY - 2015 DA - 2015// TI - A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.4499 DO - 10.18632/oncotarget.4499 ID - Chrysi2015 ER - TY - JOUR AU - Woo, Y. M. AU - Shin, Y. AU - Lee, E. J. AU - Lee, S. AU - Jeong, S. H. AU - Kong, H. K. PY - 2015 DA - 2015// TI - Inhibition of aerobic glycolysis represses Akt/mTOR/HIF-1alpha axis and restores tamoxifen sensitivity in antiestrogen-resistant breast cancer cells JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0132285 DO - 10.1371/journal.pone.0132285 ID - Woo2015 ER - TY - JOUR AU - Song, G. Q. AU - Zhao, Y. PY - 2016 DA - 2016// TI - Kisspeptin 10 inhibits the Warburg effect in breast cancer through the Smad signaling pathway: both in vitro and in vivo JO - Am J Transl Res VL - 8 ID - Song2016 ER - TY - JOUR AU - Lei, K. AU - Du, W. AU - Lin, S. AU - Yang, L. AU - Xu, Y. AU - Gao, Y. PY - 2016 DA - 2016// TI - 3B, a novel photosensitizer, inhibits glycolysis and inflammation via miR-155-5p and breaks the JAK/STAT3/SOCS1 feedback loop in human breast cancer cells JO - Biomed Pharmacother VL - 82 UR - https://doi.org/10.1016/j.biopha.2016.04.049 DO - 10.1016/j.biopha.2016.04.049 ID - Lei2016 ER - TY - JOUR AU - Kim, D. J. AU - Park, Y. S. AU - Kang, M. G. AU - You, Y. M. AU - Jung, Y. AU - Koo, H. PY - 2015 DA - 2015// TI - Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells JO - Exp Cell Res VL - 336 UR - https://doi.org/10.1016/j.yexcr.2015.05.017 DO - 10.1016/j.yexcr.2015.05.017 ID - Kim2015 ER - TY - JOUR AU - Rajeshkumar, N. V. AU - Dutta, P. AU - Yabuuchi, S. AU - Wilde, R. F. AU - Martinez, G. V. AU - Le, A. PY - 2015 DA - 2015// TI - Therapeutic targeting of the Warburg effect in pancreatic cancer relies on an absence of p53 function JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-15-0108 DO - 10.1158/0008-5472.CAN-15-0108 ID - Rajeshkumar2015 ER - TY - JOUR AU - Giovanna, B. AU - Roberto, M. AU - Silvia, R. AU - Cecilia, M. AU - Selene, C. AU - Annamaria, O. PY - 2015 DA - 2015// TI - Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3688 DO - 10.18632/oncotarget.3688 ID - Giovanna2015 ER - TY - JOUR AU - Jia, Y. AU - Ma, Z. AU - Liu, X. AU - Zhou, W. AU - He, S. AU - Xu, X. PY - 2015 DA - 2015// TI - Metformin prevents DMH-induced colorectal cancer in diabetic rats by reversing the Warburg effect JO - Cancer Med VL - 4 UR - https://doi.org/10.1002/cam4.521 DO - 10.1002/cam4.521 ID - Jia2015 ER - TY - JOUR AU - Ritterson Lew, C. AU - Guin, S. AU - Theodorescu, D. PY - 2015 DA - 2015// TI - Targeting glycogen metabolism in bladder cancer JO - Nat Rev Urol VL - 12 UR - https://doi.org/10.1038/nrurol.2015.111 DO - 10.1038/nrurol.2015.111 ID - Ritterson Lew2015 ER - TY - JOUR AU - Sanchez, W. Y. AU - McGee, S. L. AU - Connor, T. AU - Mottram, B. AU - Wilkinson, A. AU - Whitehead, J. P. PY - 2013 DA - 2013// TI - Dichloroacetate inhibits aerobic glycolysis in multiple myeloma cells and increases sensitivity to bortezomib JO - Br J Cancer VL - 108 UR - https://doi.org/10.1038/bjc.2013.120 DO - 10.1038/bjc.2013.120 ID - Sanchez2013 ER - TY - JOUR AU - Zub, K. A. AU - Sousa, M. M. AU - Sarno, A. AU - Sharma, A. AU - Demirovic, A. AU - Rao, S. PY - 2015 DA - 2015// TI - Modulation of cell metabolic pathways and oxidative stress signaling contribute to acquired melphalan resistance in multiple myeloma cells JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0119857 DO - 10.1371/journal.pone.0119857 ID - Zub2015 ER - TY - JOUR AU - Ferguson, E. C. AU - Rathmell, J. C. PY - 2008 DA - 2008// TI - New roles for pyruvate kinase M2: working out the Warburg effect JO - Trends Biochem Sci VL - 33 UR - https://doi.org/10.1016/j.tibs.2008.05.006 DO - 10.1016/j.tibs.2008.05.006 ID - Ferguson2008 ER - TY - JOUR AU - Israelsen, W. J. AU - Vander Heiden, M. G. PY - 2015 DA - 2015// TI - Pyruvate kinase: function, regulation and role in cancer JO - Semin Cell Dev Biol VL - 43 UR - https://doi.org/10.1016/j.semcdb.2015.08.004 DO - 10.1016/j.semcdb.2015.08.004 ID - Israelsen2015 ER - TY - JOUR AU - Christofk, H. R. AU - Vander Heiden, M. G. AU - Harris, M. H. AU - Ramanathan, A. AU - Gerszten, R. E. AU - Wei, R. PY - 2008 DA - 2008// TI - The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth JO - Nature VL - 452 UR - https://doi.org/10.1038/nature06734 DO - 10.1038/nature06734 ID - Christofk2008 ER - TY - JOUR AU - Yang, W. AU - Zheng, Y. AU - Xia, Y. AU - Ji, H. AU - Chen, X. AU - Guo, F. PY - 2012 DA - 2012// TI - ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect JO - Nat Cell Biol VL - 14 UR - https://doi.org/10.1038/ncb2629 DO - 10.1038/ncb2629 ID - Yang2012 ER - TY - JOUR AU - Yang, L. AU - Xie, M. AU - Yang, M. AU - Yu, Y. AU - Zhu, S. AU - Hou, W. PY - 2014 DA - 2014// TI - PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis JO - Nat Commun VL - 5 ID - Yang2014 ER - TY - JOUR AU - Hitosugi, T. AU - Kang, S. AU - Vander Heiden, M. G. AU - Chung, T. W. AU - Elf, S. AU - Lythgoe, K. PY - 2009 DA - 2009// TI - Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth JO - Sci Signal VL - 2 UR - https://doi.org/10.1126/scisignal.2000431 DO - 10.1126/scisignal.2000431 ID - Hitosugi2009 ER - TY - JOUR AU - Shi, H. S. AU - Li, D. AU - Zhang, J. AU - Wang, Y. S. AU - Yang, L. AU - Zhang, H. L. PY - 2010 DA - 2010// TI - Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice JO - Cancer Sci VL - 101 UR - https://doi.org/10.1111/j.1349-7006.2010.01562.x DO - 10.1111/j.1349-7006.2010.01562.x ID - Shi2010 ER - TY - JOUR AU - Sun, Q. AU - Chen, X. AU - Ma, J. AU - Peng, H. AU - Wang, F. AU - Zha, X. PY - 2011 DA - 2011// TI - Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth JO - Proc Natl Acad Sci U S A VL - 108 UR - https://doi.org/10.1073/pnas.1014769108 DO - 10.1073/pnas.1014769108 ID - Sun2011 ER - TY - JOUR AU - Tamada, M. AU - Suematsu, M. AU - Saya, H. PY - 2012 DA - 2012// TI - Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-0859 DO - 10.1158/1078-0432.CCR-12-0859 ID - Tamada2012 ER - TY - JOUR AU - Cortes-Cros, M. AU - Hemmerlin, C. AU - Ferretti, S. AU - Zhang, J. AU - Gounarides, J. S. AU - Yin, H. PY - 2013 DA - 2013// TI - M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth JO - Proc Natl Acad Sci U S A VL - 110 UR - https://doi.org/10.1073/pnas.1212780110 DO - 10.1073/pnas.1212780110 ID - Cortes-Cros2013 ER - TY - JOUR AU - Jiang, Y. AU - Li, X. AU - Yang, W. AU - Hawke, D. H. AU - Zheng, Y. AU - Xia, Y. PY - 2014 DA - 2014// TI - PKM2 regulates chromosome segregation and mitosis progression of tumor cells JO - Mol Cell VL - 53 UR - https://doi.org/10.1016/j.molcel.2013.11.001 DO - 10.1016/j.molcel.2013.11.001 ID - Jiang2014 ER - TY - JOUR AU - Chen, M. AU - Zhang, J. AU - Manley, J. L. PY - 2010 DA - 2010// TI - Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-10-2513 DO - 10.1158/0008-5472.CAN-10-2513 ID - Chen2010 ER - TY - JOUR AU - Clower, C. V. AU - Chatterjee, D. AU - Wang, Z. AU - Cantley, L. C. AU - Vander Heiden, M. G. AU - Krainer, A. R. PY - 2010 DA - 2010// TI - The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism JO - Proc Natl Acad Sci U S A VL - 107 UR - https://doi.org/10.1073/pnas.0914845107 DO - 10.1073/pnas.0914845107 ID - Clower2010 ER - TY - JOUR AU - David, C. J. AU - Chen, M. AU - Assanah, M. AU - Canoll, P. AU - Manley, J. L. PY - 2010 DA - 2010// TI - HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer JO - Nature VL - 463 UR - https://doi.org/10.1038/nature08697 DO - 10.1038/nature08697 ID - David2010 ER - TY - JOUR AU - Mardin, B. R. AU - Lange, C. AU - Baxter, J. E. AU - Hardy, T. AU - Scholz, S. R. AU - Fry, A. M. PY - 2010 DA - 2010// TI - Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction JO - Nat Cell Biol VL - 12 UR - https://doi.org/10.1038/ncb2120 DO - 10.1038/ncb2120 ID - Mardin2010 ER - TY - JOUR AU - Zhou, W. AU - Yang, Y. AU - Xia, J. AU - Wang, H. AU - Salama, M. E. AU - Xiong, W. PY - 2013 DA - 2013// TI - NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers JO - Cancer Cell VL - 23 UR - https://doi.org/10.1016/j.ccr.2012.12.001 DO - 10.1016/j.ccr.2012.12.001 ID - Zhou2013 ER - TY - JOUR AU - Cappello, P. AU - Blaser, H. AU - Gorrini, C. AU - Lin, D. C. AU - Elia, A. J. AU - Wakeham, A. PY - 2014 DA - 2014// TI - Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells JO - Oncogene VL - 33 UR - https://doi.org/10.1038/onc.2013.183 DO - 10.1038/onc.2013.183 ID - Cappello2014 ER - TY - JOUR AU - Yang, Y. AU - Zhou, W. AU - Xia, J. AU - Gu, Z. AU - Wendlandt, E. AU - Zhan, X. PY - 2014 DA - 2014// TI - NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma JO - Oncotarget VL - 5 UR - https://doi.org/10.18632/oncotarget.2388 DO - 10.18632/oncotarget.2388 ID - Yang2014 ER - TY - JOUR AU - Xia, J. AU - Franqui Machin, R. AU - Gu, Z. AU - Zhan, F. PY - 2015 DA - 2015// TI - Role of NEK2A in human cancer and its therapeutic potentials JO - Biomed Res Int VL - 2015 ID - Xia2015 ER - TY - JOUR AU - Naro, C. AU - Barbagallo, F. AU - Chieffi, P. AU - Bourgeois, C. F. AU - Paronetto, M. P. AU - Sette, C. PY - 2014 DA - 2014// TI - The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival JO - Nucleic Acids Res VL - 42 UR - https://doi.org/10.1093/nar/gkt1307 DO - 10.1093/nar/gkt1307 ID - Naro2014 ER - TY - JOUR AU - Zhan, F. AU - Barlogie, B. AU - Arzoumanian, V. AU - Huang, Y. AU - Williams, D. R. AU - Hollmig, K. PY - 2007 DA - 2007// TI - Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-07-037077 DO - 10.1182/blood-2006-07-037077 ID - Zhan2007 ER - TY - JOUR AU - Phizicky, E. M. AU - Fields, S. PY - 1995 DA - 1995// TI - Protein-protein interactions: methods for detection and analysis JO - Microbiol Rev VL - 59 ID - Phizicky1995 ER - TY - JOUR AU - Selth, L. A. AU - Gilbert, C. AU - Svejstrup, J. Q. PY - 2009 DA - 2009// TI - RNA immunoprecipitation to determine RNA-protein associations in vivo JO - Cold Spring Harb Protoc VL - 2009 UR - https://doi.org/10.1101/pdb.prot5234 DO - 10.1101/pdb.prot5234 ID - Selth2009 ER - TY - JOUR AU - Toyoshima, M. AU - Howie, H. L. AU - Imakura, M. AU - Walsh, R. M. AU - Annis, J. E. AU - Chang, A. N. PY - 2012 DA - 2012// TI - Functional genomics identifies therapeutic targets for MYC-driven cancer JO - Proc Natl Acad Sci U S A VL - 109 UR - https://doi.org/10.1073/pnas.1121119109 DO - 10.1073/pnas.1121119109 ID - Toyoshima2012 ER - TY - JOUR AU - Chung, E. Y. AU - Psathas, J. N. AU - Yu, D. AU - Li, Y. AU - Weiss, M. J. AU - Thomas-Tikhonenko, A. PY - 2012 DA - 2012// TI - CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis JO - J Clin Invest VL - 122 UR - https://doi.org/10.1172/JCI45851 DO - 10.1172/JCI45851 ID - Chung2012 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2000 DA - 2000// TI - The hallmarks of cancer JO - Cell VL - 100 UR - https://doi.org/10.1016/S0092-8674(00)81683-9 DO - 10.1016/S0092-8674(00)81683-9 ID - Hanahan2000 ER - TY - JOUR AU - Duncan, K. AU - Rosean, T. R. AU - Tompkins, V. S. AU - Olivier, A. AU - Sompallae, R. AU - Zhan, F. PY - 2013 DA - 2013// TI - 18F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib JO - Blood Cancer J VL - 3 UR - https://doi.org/10.1038/bcj.2013.61 DO - 10.1038/bcj.2013.61 ID - Duncan2013 ER - TY - JOUR AU - Zeller, K. I. AU - Zhao, X. AU - Lee, C. W. AU - Chiu, K. P. AU - Yao, F. AU - Yustein, J. T. PY - 2006 DA - 2006// TI - Global mapping of c-Myc binding sites and target gene networks in human B cells JO - Proc Natl Acad Sci U S A VL - 103 UR - https://doi.org/10.1073/pnas.0604129103 DO - 10.1073/pnas.0604129103 ID - Zeller2006 ER - TY - JOUR AU - Dib, A. AU - Gabrea, A. AU - Glebov, O. K. AU - Bergsagel, P. L. AU - Kuehl, W. M. PY - 2008 DA - 2008// TI - Characterization of MYC translocations in multiple myeloma cell lines JO - J Natl Cancer Inst Monogr VL - 39 UR - https://doi.org/10.1093/jncimonographs/lgn011 DO - 10.1093/jncimonographs/lgn011 ID - Dib2008 ER - TY - JOUR AU - Holien, T. AU - Vatsveen, T. K. AU - Hella, H. AU - Waage, A. AU - Sundan, A. PY - 2012 DA - 2012// TI - Addiction to c-MYC in multiple myeloma JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2011-08-371567 DO - 10.1182/blood-2011-08-371567 ID - Holien2012 ER -